| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
168 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
854 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
266 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
743 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
866 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6028103 |
Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation |
Feb. 22, 2000 |
| 6025350 |
C-4" substituted macrolide antibiotics |
Feb. 15, 2000 |
| 6025364 |
Method of treating asthma |
Feb. 15, 2000 |
| 6017943 |
Hemoglobin crosslinkers |
Jan. 25, 2000 |
| 6015807 |
Protein kinase C inhibitor |
Jan. 18, 2000 |
| 6015808 |
Synthesis of pharmaceutical compositions with lactams and .beta.-lactams/oxo thia azabicyclo compounds |
Jan. 18, 2000 |
| 6011028 |
Cyclic amidino agents useful as nitric oxide synthase inhibitors |
Jan. 4, 2000 |
| 6011041 |
Use of anhydrovinblastine |
Jan. 4, 2000 |
| 6011045 |
Vitronectin receptor antagonists, their preparation and their use |
Jan. 4, 2000 |
| 6004949 |
Aqueous composition containing cromoglycic acid |
Dec. 21, 1999 |
| 6004950 |
2-aminopyridines as inhibitors of cyclooxygenase-2 |
Dec. 21, 1999 |
| 6004961 |
1,4-disubstituted piperazines |
Dec. 21, 1999 |
| 6004977 |
N-(pyridinylamino) isoindolines and related compounds |
Dec. 21, 1999 |
| 6005007 |
Retinoids, methods for their production and use |
Dec. 21, 1999 |
| 6001826 |
Chemical compounds |
Dec. 14, 1999 |
| 5998402 |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
Dec. 7, 1999 |
| 5998405 |
Fused tropane-derivatives as neurotransmitter reuptake inhibitors |
Dec. 7, 1999 |
| 5998409 |
Condensed indole derivatives as 5HT.sub.4 -receptor antagonists |
Dec. 7, 1999 |
| 5994338 |
Stabilized pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation |
Nov. 30, 1999 |
| 5994347 |
For a process for treatment of anxiety and tension |
Nov. 30, 1999 |
| 5994373 |
Substituted azacyclic compounds |
Nov. 30, 1999 |
| 5994390 |
Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Nov. 30, 1999 |
| 5989832 |
Method for screening for non-tetracycline efflux pump inhibitors |
Nov. 23, 1999 |
| 5989876 |
Colorant precursors derivable from cells of plants of the genus medicago, process for their preparation and use thereof for the preparation of colorants |
Nov. 23, 1999 |
| 5985863 |
Compositions and methods for decreasing IGIF and IFN-.gamma. production by administering an ICE inhibitor |
Nov. 16, 1999 |
| 5985869 |
Benzoheterocyclic compounds |
Nov. 16, 1999 |
| 5985878 |
Angiogenesis inhibiting pyridazinamines |
Nov. 16, 1999 |
| 5985917 |
Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
Nov. 16, 1999 |
| 5981524 |
Substituted 9-alkyladenines |
Nov. 9, 1999 |
| 5981534 |
Fungicidal 6-(2,6-difluoro-4-alkoxyphenyl)-triazolopyrimidines |
Nov. 9, 1999 |
| 5977100 |
Substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof |
Nov. 2, 1999 |
| 5977177 |
Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them |
Nov. 2, 1999 |
| 5972349 |
Synthesis of polyribosylribitol phosphate oligosaccharides |
Oct. 26, 1999 |
| 5972924 |
Treatment of cerebral ischemia and cerebral damage with neuroprotective agents |
Oct. 26, 1999 |
| 5972925 |
Heterocyclic compounds |
Oct. 26, 1999 |
| 5968478 |
N- methyl piperazine compounds having dopamine receptor affinity |
Oct. 19, 1999 |
| 5968920 |
Compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
Oct. 19, 1999 |
| 5968921 |
Compositions and methods for promoting nerve regeneration |
Oct. 19, 1999 |
| 5968936 |
Methods for treating or preventing Alzheimer's Disease using substituted 1-aryl-3-morpholinopropanones |
Oct. 19, 1999 |
| 5965565 |
Piperidines promote release of growth hormone |
Oct. 12, 1999 |
| 5965573 |
Compositions and methods for treating bone deficit conditions |
Oct. 12, 1999 |
| 5965598 |
Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents |
Oct. 12, 1999 |
| 5962446 |
Therapetutic treatment for human T cell lymphotrophic virus type 1 infection |
Oct. 5, 1999 |
| 5962498 |
Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity |
Oct. 5, 1999 |
| 5958920 |
Aralkyl diazabicycloalkane derivatives for CNS disorders |
Sep. 28, 1999 |
| 5955457 |
Water soluble rapamycin esters |
Sep. 21, 1999 |
| 5952320 |
Macrocyclic inhibitors of matrix metalloproteinases and TNF.alpha. secretion |
Sep. 14, 1999 |
| 5952334 |
Carbocyclic compounds |
Sep. 14, 1999 |
| 5948770 |
Antifungal macrolides and their synthesis |
Sep. 7, 1999 |
| 5945315 |
Method for producing cryptophycins by cultivating a Nostoc sp. |
Aug. 31, 1999 |
|
|
|
